Actively Recruiting
Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)
Led by Karolinska University Hospital · Updated on 2025-09-05
94
Participants Needed
1
Research Sites
161 weeks
Total Duration
On this page
Sponsors
K
Karolinska University Hospital
Lead Sponsor
U
University Hospital, Linkoeping
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Robocop trial is an international multi-centre, single blinded, randomized controlled superiority trial conducted in centres experienced in robotic-assisted liver surgery. Eligible patients for radical cholecystectomy will be randomized in a 1:1 ratio to undergo robotic-assisted or open resection within an enhanced recovery setting. The primary endpoint is time to functional recovery. Secondary endpoints include length of hospital stay, resection margin, number of retrieved lymph nodes, postoperative complications, quality of life, abdominal wall complaints and direct and indirect costs.
CONDITIONS
Official Title
Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with radiologically suspected or confirmed (≥T1b) incidental gallbladder cancer after cholecystectomy with an indication of radical cholecystectomy, without the need for resection of extrahepatic bile ducts, as decided at a multidisciplinary team conference.
- Patient sufficiently fit to undergo radical cholecystectomy according to surgeon and anaesthesiologist.
You will not qualify if you...
- Previous extensive surgery in the upper abdomen (for example open liver surgery)
- Pregnancy
- Intraoperative findings of dissemination (patient is then excluded after randomization)
- Intraoperative findings of the need to perform resection of extrahepatic bile ducts (patient is then excluded after randomization).
- Intraoperative findings leading to a simple cholecystectomy only (patient is then excluded after randomization)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Region Stockholm
Stockholm, Sweden
Actively Recruiting
Research Team
C
Christian Sturesson, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here